Showing results (191-200 of 213) with videos related to
Sort By:
Pageof 22
Lancet (London, England)|November 30, 2013
Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)Pam Sonnenberg, Soazig Clifton, Simon Beddows, et al.Pediatric Blood & Cancer|September 17, 2022
Answers to common questions about COVID-19 vaccines in children with cancerMiguela A Caniza, Maysam R Homsi, Jessica Bate, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group StudySarah Alexander, John A Kairalla, Sumit Gupta, et al.The Lancet. Oncology|December 19, 2015
Classification of treatment-related mortality in children with cancer: a systematic assessmentSarah Alexander, Jason D Pole, Paul Gibson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantationThomas Lehrnbecher, Robert Phillips, Sarah Alexander, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2017
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 UpdateThomas Lehrnbecher, Paula Robinson, Brian Fisher, et al.Microbial Genomics|May 17, 2023
NCTC3000: a century of bacterial strain collecting leads to a rich genomic data resourceJo Dicks, Mohammed-Abbas Fazal, Karen Oliver, et al.The Lancet. Haematology|April 24, 2023
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trialSarah Alexander, Anne Aupérin, Simon Bomken, et al.Leukemia|September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Richard Sposto, Nirali N Shah, et al.Leukemia|March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Richard Sposto, Nirali N Shah, et al.Pageof 22